Be the first to review this item
Memotropil (Piracetamum, Piracetam) - nootropics. It has a positive effect on the metabolism and blood circulation of the brain. It increases glucose utilization, improves the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets. It has a protective effect in brain damage caused by hypoxia, intoxication, electroshock. Improves the integrative activity of the brain. No sedative and stimulating effect.
Memotropil - active ingredient is Piracetam, a cyclic derivative of gamma-aminobutyric acid (SAVA).
Piracetam is a nootropic agent that acts directly on the brain improving the cognitive (cognitive) processes, such as learning ability, memory, attention, as well as mental performance. It affects the central nervous system in different ways: changing the plane of propagation of excitation in the brain, improving metabolic processes in nerve cells, improving microcirculation by acting on the rheological characteristics of blood and causing no vasodilatory action.
Improves communication between the hemispheres of the brain and synaptic conductance in neocortical structures, improves mental performance, improves cerebral blood flow. Piracetam inhibits platelet aggregation and restores erythrocyte membrane elasticity and reduces the adhesion of erythrocytes. At a dose of 9.6 g reduces levels of fibrinogen and von Willebrand factor. 30% - 40% and prolong bleeding time.
It reduces the severity and duration of vestibular nystagmus
Memotropil - It stimulates metabolism in the brain increases the concentration of ATP, amplifies biosynthesis of RNA and phospholipids glycolytic processes glucose utilization. Improves the integrative activity of the brain contributes to memory consolidation, it facilitates the learning process.
Hemorrhagic stroke, severe renal insufficiency (with creatinine clearance <20 mL / min), hypersensitivity to piracetam.
Inside, regardless of meals, drinking plenty of fluids. Daily dose - 30-160 mg / kg, the multiplicity of reception - 2-4 times a day.
Symptomatic treatment of chronic psycho-organic syndrome, depending on the severity of symptoms, administered 1.2-2.4 g, and during the first week of treatment - 4.8 g / day.
In the treatment of the effects of stroke - 4.8 g / day.
When alcohol withdrawal syndrome - 12 g / day. The maintenance dose - 2.4 g / day.
Treatment of vertigo and associated balance disorders - 2,4-4,8 g / day.
Children (for the correction of learning disabilities) - 3.3 g / day for the entire school year.
When cortical myoclonus initial dose - 7.2 g / day every 3-4 days the dose is increased to 4.8 g / day to a maximum dose - 24 g / day. Treatment continues throughout the period of illness. Every 6 months, attempts to reduce the dose or discontinuation of the drug. To prevent the attack of reducing the dose gradually, by 1.2 g every two days. If there is no effect or little therapeutic effect of the treatment is stopped.
In sickle cell anemia prophylactic daily dose of 160 mg / kg, divided into 4 equal doses.
Important notice- the outer box design may vary before prior notice!